메뉴 건너뛰기




Volumn 18, Issue 1, 2017, Pages

Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers

Author keywords

Antiparasitic; Antiretroviral; Caco 2 cell monolayers; Drug interactions; Drug transport; Intestinal epithelium; TEER

Indexed keywords

ANTHELMINTIC AGENT; ANTIRETROVIRUS AGENT; EFAVIRENZ; IVERMECTIN; LOPINAVIR; NEVIRAPINE; PRAZIQUANTEL; SAQUINAVIR;

EID: 85018252279     PISSN: None     EISSN: 20506511     Source Type: Journal    
DOI: 10.1186/s40360-017-0129-6     Document Type: Article
Times cited : (26)

References (100)
  • 1
    • 77954572990 scopus 로고    scopus 로고
    • Multiparasitism a neglected reality on global, regional and local scale
    • Steinmann P, Utzinger J, Du ZW, Zhou XN. Multiparasitism a neglected reality on global, regional and local scale. Adv Parasitol. 2010;73:21-50.
    • (2010) Adv Parasitol , vol.73 , pp. 21-50
    • Steinmann, P.1    Utzinger, J.2    Du, Z.W.3    Zhou, X.N.4
  • 2
    • 20044364593 scopus 로고    scopus 로고
    • Review: mixing new cocktails: drug interactions in antiretroviral regimens
    • Young B. Review: mixing new cocktails: drug interactions in antiretroviral regimens. AIDS Patient Care STDS. 2005;19:286-97.
    • (2005) AIDS Patient Care STDS , vol.19 , pp. 286-297
    • Young, B.1
  • 4
    • 33846404121 scopus 로고    scopus 로고
    • Interactions of antiretroviral drugs with anti-infectives and other antiretrovirals
    • Pontali E. Interactions of antiretroviral drugs with anti-infectives and other antiretrovirals. Chemotherapy. 2007;53:26-9.
    • (2007) Chemotherapy , vol.53 , pp. 26-29
    • Pontali, E.1
  • 5
    • 84876396409 scopus 로고    scopus 로고
    • Drug-drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases
    • Seden K, Khoo S, Back D, Prevatt N, Lamorde M, Byakika-Kibwika P, Mayito J, Ryan M, Merry C. Drug-drug interactions between antiretrovirals and drugs used in the management of neglected tropical diseases: important considerations in the WHO 2020 Roadmap and London Declaration on Neglected Tropical Diseases. AIDS (London, England). 2013;27:675--686.
    • (2013) AIDS (London, England) , vol.27 , pp. 675-686
    • Seden, K.1    Khoo, S.2    Back, D.3    Prevatt, N.4    Lamorde, M.5    Byakika-Kibwika, P.6    Mayito, J.7    Ryan, M.8    Merry, C.9
  • 6
    • 84872811617 scopus 로고    scopus 로고
    • Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages
    • Zha W, Wang G, Xu W, Liu X, Wang Y, Zha BS, Shi J, Zhao Q, Gerk PM, Studer E, et al. Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages. PLoS One. 2013;8:e54349.
    • (2013) PLoS One , vol.8
    • Zha, W.1    Wang, G.2    Xu, W.3    Liu, X.4    Wang, Y.5    Zha, B.S.6    Shi, J.7    Zhao, Q.8    Gerk, P.M.9    Studer, E.10
  • 7
    • 0035198013 scopus 로고    scopus 로고
    • Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs
    • Patel J, Mitra AK. Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs. Pharmacogenomics. 2001;2:401-15.
    • (2001) Pharmacogenomics , vol.2 , pp. 401-415
    • Patel, J.1    Mitra, A.K.2
  • 8
    • 77954427586 scopus 로고    scopus 로고
    • Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells
    • Dupuy J, Alvinerie M, Menez C, Lespine A. Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells. Chem Biol Interact. 2010;186:280-6.
    • (2010) Chem Biol Interact , vol.186 , pp. 280-286
    • Dupuy, J.1    Alvinerie, M.2    Menez, C.3    Lespine, A.4
  • 9
    • 84955335675 scopus 로고    scopus 로고
    • Drug-Drug Interaction: Enzyme Induction
    • In: Vogel HG, Maas J, Hock FJ, Mayer D, editors, Berlin: Springer
    • Bünning P. Drug-Drug Interaction: Enzyme Induction. In: Vogel HG, Maas J, Hock FJ, Mayer D, editors. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Berlin: Springer; 2013. p. 975-87.
    • (2013) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays , pp. 975-987
    • Bünning, P.1
  • 10
    • 84932172189 scopus 로고    scopus 로고
    • Interplay of drug-metabolizing enzymes and transporters in drug absorption and disposition
    • Shi S, Li Y. Interplay of drug-metabolizing enzymes and transporters in drug absorption and disposition. Curr Drug Metab. 2014;15:915-41.
    • (2014) Curr Drug Metab , vol.15 , pp. 915-941
    • Shi, S.1    Li, Y.2
  • 11
    • 84878359254 scopus 로고    scopus 로고
    • Transporters and drug-drug interactions: important determinants of drug disposition and effects
    • Konig J, Muller F, Fromm MF. Transporters and drug-drug interactions: important determinants of drug disposition and effects. Pharmacol Rev. 2013;65:944-66.
    • (2013) Pharmacol Rev , vol.65 , pp. 944-966
    • Konig, J.1    Muller, F.2    Fromm, M.F.3
  • 12
    • 2542453938 scopus 로고    scopus 로고
    • Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins
    • Gimenez F, Fernandez C, Mabondzo A. Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins. J Acquir Immune Defic Syndr. 2004;36:649-58.
    • (2004) J Acquir Immune Defic Syndr , vol.36 , pp. 649-658
    • Gimenez, F.1    Fernandez, C.2    Mabondzo, A.3
  • 13
    • 79960771381 scopus 로고    scopus 로고
    • Transporter-mediated drug-drug interactions
    • Muller F, Fromm MF. Transporter-mediated drug-drug interactions. Pharmacogenomics. 2011;12:1017-37.
    • (2011) Pharmacogenomics , vol.12 , pp. 1017-1037
    • Muller, F.1    Fromm, M.F.2
  • 14
  • 15
    • 49649120671 scopus 로고    scopus 로고
    • Intestinal efflux transporters and drug absorption
    • Murakami T, Takano M. Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol. 2008;4:923-39.
    • (2008) Expert Opin Drug Metab Toxicol , vol.4 , pp. 923-939
    • Murakami, T.1    Takano, M.2
  • 16
    • 45249121177 scopus 로고    scopus 로고
    • Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4
    • Zhou SF. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab. 2008;9:310-22.
    • (2008) Curr Drug Metab , vol.9 , pp. 310-322
    • Zhou, S.F.1
  • 17
    • 0033371825 scopus 로고    scopus 로고
    • Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors
    • Profit L, Eagling VA, Back DJ. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. AIDS. 1999;13:1623-7.
    • (1999) AIDS , vol.13 , pp. 1623-1627
    • Profit, L.1    Eagling, V.A.2    Back, D.J.3
  • 18
    • 0032518290 scopus 로고    scopus 로고
    • The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
    • Kim RB, Fromm MF, Wandel C, Leake B, Wood AJ, Roden DM, Wilkinson GR. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest. 1998;101:289-94.
    • (1998) J Clin Invest , vol.101 , pp. 289-294
    • Kim, R.B.1    Fromm, M.F.2    Wandel, C.3    Leake, B.4    Wood, A.J.5    Roden, D.M.6    Wilkinson, G.R.7
  • 20
    • 0031896882 scopus 로고    scopus 로고
    • Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers
    • Alsenz J, Steffen H, Alex R. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers. Pharm Res. 1998;15:423-8.
    • (1998) Pharm Res , vol.15 , pp. 423-428
    • Alsenz, J.1    Steffen, H.2    Alex, R.3
  • 21
    • 23744453405 scopus 로고    scopus 로고
    • The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors
    • Wang X, Baba M. The role of breast cancer resistance protein (BCRP/ABCG2) in cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Antivir Chem Chemother. 2005;16:213-6.
    • (2005) Antivir Chem Chemother , vol.16 , pp. 213-216
    • Wang, X.1    Baba, M.2
  • 22
    • 81155159797 scopus 로고    scopus 로고
    • Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat
    • Peroni RN, Di Gennaro SS, Hocht C, Chiappetta DA, Rubio MC, Sosnik A, Bramuglia GF. Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat. Biochem Pharmacol. 2011;82:1227-33.
    • (2011) Biochem Pharmacol , vol.82 , pp. 1227-1233
    • Peroni, R.N.1    Gennaro, S.S.2    Hocht, C.3    Chiappetta, D.A.4    Rubio, M.C.5    Sosnik, A.6    Bramuglia, G.F.7
  • 24
    • 0035997339 scopus 로고    scopus 로고
    • Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture
    • Stormer E, von Moltke LL, Perloff MD, Greenblatt DJ. Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture. Pharm Res. 2002;19:1038-45.
    • (2002) Pharm Res , vol.19 , pp. 1038-1045
    • Stormer, E.1    Moltke, L.L.2    Perloff, M.D.3    Greenblatt, D.J.4
  • 25
    • 79952355540 scopus 로고    scopus 로고
    • Interaction potential of etravirine with drug transporters assessed in vitro
    • Zembruski NC, Haefeli WE, Weiss J. Interaction potential of etravirine with drug transporters assessed in vitro. Antimicrob Agents Chemother. 2011;55:1282-4.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 1282-1284
    • Zembruski, N.C.1    Haefeli, W.E.2    Weiss, J.3
  • 26
    • 84876297950 scopus 로고    scopus 로고
    • Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro
    • Weiss J, Haefeli WE. Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro. Int J Antimicrob Agents. 2013;41:484-7.
    • (2013) Int J Antimicrob Agents , vol.41 , pp. 484-487
    • Weiss, J.1    Haefeli, W.E.2
  • 28
    • 85013876354 scopus 로고    scopus 로고
    • Recent Advances in Antischistosomal Drugs and Agents
    • Liu L, Li-Li J, Qiong C, Xiao-Lin F.
    • Liu L, Li-Li J, Qiong C, Xiao-Lin F. "Recent Advances in Antischistosomal Drugs and Agents." Mini reviews in medicinal chemistry. 2017;17(5):467-84.
    • (2017) Mini reviews in medicinal chemistry , vol.17 , Issue.5 , pp. 467-484
  • 29
    • 33745436655 scopus 로고    scopus 로고
    • Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk
    • Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411-25.
    • (2006) Lancet Infect Dis , vol.6 , pp. 411-425
    • Steinmann, P.1    Keiser, J.2    Bos, R.3    Tanner, M.4    Utzinger, J.5
  • 31
    • 33646823291 scopus 로고    scopus 로고
    • Lymphatic filariasis: treatment, control and elimination
    • Ottesen EA. Lymphatic filariasis: treatment, control and elimination. Adv Parasitol. 2006;61:395-441.
    • (2006) Adv Parasitol , vol.61 , pp. 395-441
    • Ottesen, E.A.1
  • 35
    • 37349020802 scopus 로고    scopus 로고
    • Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers
    • Brayden DJ, Griffin J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Vet Res Commun. 2008;32:93-106.
    • (2008) Vet Res Commun , vol.32 , pp. 93-106
    • Brayden, D.J.1    Griffin, J.2
  • 37
    • 33344474213 scopus 로고    scopus 로고
    • Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments
    • Ballent M, Lifschitz A, Virkel G, Sallovitz J, Lanusse C. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab Dispos. 2006;34:457-63.
    • (2006) Drug Metab Dispos , vol.34 , pp. 457-463
    • Ballent, M.1    Lifschitz, A.2    Virkel, G.3    Sallovitz, J.4    Lanusse, C.5
  • 38
    • 45449101104 scopus 로고    scopus 로고
    • ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics
    • Lespine A, Alvinerie M, Vercruysse J, Prichard RK, Geldhof P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol. 2008;24:293-8.
    • (2008) Trends Parasitol , vol.24 , pp. 293-298
    • Lespine, A.1    Alvinerie, M.2    Vercruysse, J.3    Prichard, R.K.4    Geldhof, P.5
  • 40
    • 33748062666 scopus 로고    scopus 로고
    • The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux
    • Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur J Pharm Sci. 2006;29:70-81.
    • (2006) Eur J Pharm Sci , vol.29 , pp. 70-81
    • Hayeshi, R.1    Masimirembwa, C.2    Mukanganyama, S.3    Ungell, A.L.4
  • 42
    • 34250673662 scopus 로고    scopus 로고
    • Biotransformation of praziquantel by human cytochrome p450 3A4 (CYP 3A4)
    • Godawska-Matysik A, Kiec-Kononowicz K. Biotransformation of praziquantel by human cytochrome p450 3A4 (CYP 3A4). Acta Pol Pharm. 2006;63:381-5.
    • (2006) Acta Pol Pharm , vol.63 , pp. 381-385
    • Godawska-Matysik, A.1    Kiec-Kononowicz, K.2
  • 43
    • 36249009758 scopus 로고    scopus 로고
    • Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers
    • Ridtitid W, Ratsamemonthon K, Mahatthanatrakul W, Wongnawa M. Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers. J Clin Pharm Ther. 2007;32:585-93.
    • (2007) J Clin Pharm Ther , vol.32 , pp. 585-593
    • Ridtitid, W.1    Ratsamemonthon, K.2    Mahatthanatrakul, W.3    Wongnawa, M.4
  • 44
    • 33748887871 scopus 로고    scopus 로고
    • Caco-2 cell permeability assays to measure drug absorption
    • van Breemen RB, Li Y. Caco-2 cell permeability assays to measure drug absorption. Expert Opin Drug Metab Toxicol. 2005;1:175-85.
    • (2005) Expert Opin Drug Metab Toxicol , vol.1 , pp. 175-185
    • Breemen, R.B.1    Li, Y.2
  • 45
    • 84981747436 scopus 로고    scopus 로고
    • Intracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing)
    • Kigen G, Edwards G. Intracellular accumulation of Praziquantel in T lymphoblastoid cell lines, CEM (parental) and CEMVBL(P-gp-overexpressing). BMC Pharmacol Toxicol. 2016;17:37.
    • (2016) BMC Pharmacol Toxicol , vol.17 , pp. 37
    • Kigen, G.1    Edwards, G.2
  • 46
    • 0031925268 scopus 로고    scopus 로고
    • Human intestinal permeability
    • Lennernas H. Human intestinal permeability. J Pharm Sci. 1998;87:403-10.
    • (1998) J Pharm Sci , vol.87 , pp. 403-410
    • Lennernas, H.1
  • 47
    • 33750144064 scopus 로고    scopus 로고
    • Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract
    • Masaoka Y, Tanaka Y, Kataoka M, Sakuma S, Yamashita S. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. Eur J Pharm Sci. 2006;29:240-50.
    • (2006) Eur J Pharm Sci , vol.29 , pp. 240-250
    • Masaoka, Y.1    Tanaka, Y.2    Kataoka, M.3    Sakuma, S.4    Yamashita, S.5
  • 48
    • 0029102179 scopus 로고
    • Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers
    • Adson A, Burton PS, Raub TJ, Barsuhn CL, Audus KL, Ho NF. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci. 1995;84:1197-204.
    • (1995) J Pharm Sci , vol.84 , pp. 1197-1204
    • Adson, A.1    Burton, P.S.2    Raub, T.J.3    Barsuhn, C.L.4    Audus, K.L.5    Ho, N.F.6
  • 49
    • 0025311288 scopus 로고
    • Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
    • Artursson P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci. 1990;79:476-82.
    • (1990) J Pharm Sci , vol.79 , pp. 476-482
    • Artursson, P.1
  • 50
    • 32344446760 scopus 로고    scopus 로고
    • Role of Caco-2 cell monolayers in prediction of intestinal drug absorption
    • Shah P, Jogani V, Bagchi T, Misra A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol Prog. 2006;22:186-98.
    • (2006) Biotechnol Prog , vol.22 , pp. 186-198
    • Shah, P.1    Jogani, V.2    Bagchi, T.3    Misra, A.4
  • 51
    • 0025804183 scopus 로고
    • Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
    • Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991;175:880-5.
    • (1991) Biochem Biophys Res Commun , vol.175 , pp. 880-885
    • Artursson, P.1    Karlsson, J.2
  • 52
    • 0035286778 scopus 로고    scopus 로고
    • Caco-2 monolayers in experimental and theoretical predictions of drug transport
    • Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev. 2001;46:27-43.
    • (2001) Adv Drug Deliv Rev , vol.46 , pp. 27-43
    • Artursson, P.1    Palm, K.2    Luthman, K.3
  • 53
    • 0031780682 scopus 로고    scopus 로고
    • Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line
    • Gres MC, Julian B, Bourrie M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm Res. 1998;15:726-33.
    • (1998) Pharm Res , vol.15 , pp. 726-733
    • Gres, M.C.1    Julian, B.2    Bourrie, M.3    Meunier, V.4    Roques, C.5    Berger, M.6    Boulenc, X.7    Berger, Y.8    Fabre, G.9
  • 55
    • 0024593744 scopus 로고
    • Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability
    • Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989;96:736-49.
    • (1989) Gastroenterology , vol.96 , pp. 736-749
    • Hidalgo, I.J.1    Raub, T.J.2    Borchardt, R.T.3
  • 56
    • 0025132942 scopus 로고
    • Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa
    • Hilgers AR, Conradi RA, Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res. 1990;7:902-10.
    • (1990) Pharm Res , vol.7 , pp. 902-910
    • Hilgers, A.R.1    Conradi, R.A.2    Burton, P.S.3
  • 57
    • 20044371666 scopus 로고    scopus 로고
    • The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics
    • Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005;21:1-26.
    • (2005) Cell Biol Toxicol , vol.21 , pp. 1-26
    • Sambuy, Y.1    Angelis, I.2    Ranaldi, G.3    Scarino, M.L.4    Stammati, A.5    Zucco, F.6
  • 58
    • 0027181852 scopus 로고
    • Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators
    • Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J Biol Chem. 1993;268:14991-7.
    • (1993) J Biol Chem , vol.268 , pp. 14991-14997
    • Hunter, J.1    Jepson, M.A.2    Tsuruo, T.3    Simmons, N.L.4    Hirst, B.H.5
  • 59
    • 0033985306 scopus 로고    scopus 로고
    • Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)
    • Hirohashi T, Suzuki H, Chu XY, Tamai I, Tsuji A, Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J Pharmacol Exp Ther. 2000;292:265-70.
    • (2000) J Pharmacol Exp Ther , vol.292 , pp. 265-270
    • Hirohashi, T.1    Suzuki, H.2    Chu, X.Y.3    Tamai, I.4    Tsuji, A.5    Sugiyama, Y.6
  • 61
    • 0024789567 scopus 로고
    • Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2
    • Peters WH, Roelofs HM. Time-dependent activity and expression of glutathione S-transferases in the human colon adenocarcinoma cell line Caco-2. Biochem J. 1989;264:613-6.
    • (1989) Biochem J , vol.264 , pp. 613-616
    • Peters, W.H.1    Roelofs, H.M.2
  • 62
    • 0035524138 scopus 로고    scopus 로고
    • Assessing the absorption of new pharmaceuticals
    • Hidalgo IJ. Assessing the absorption of new pharmaceuticals. Curr Top Med Chem. 2001;1:385-401.
    • (2001) Curr Top Med Chem , vol.1 , pp. 385-401
    • Hidalgo, I.J.1
  • 63
    • 0346216088 scopus 로고    scopus 로고
    • Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis
    • Alsenz J, Haenel E. Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis. Pharm Res. 2003;20:1961-9.
    • (2003) Pharm Res , vol.20 , pp. 1961-1969
    • Alsenz, J.1    Haenel, E.2
  • 64
    • 0025358551 scopus 로고
    • Transport of bile acids in a human intestinal epithelial cell line, Caco-2
    • Hidalgo IJ, Borchardt RT. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim Biophys Acta. 1990;1035:97-103.
    • (1990) Biochim Biophys Acta , vol.1035 , pp. 97-103
    • Hidalgo, I.J.1    Borchardt, R.T.2
  • 66
  • 67
    • 0347989382 scopus 로고    scopus 로고
    • In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model
    • Bravo SA, Nielsen CU, Amstrup J, Frokjaer S, Brodin B. In-depth evaluation of Gly-Sar transport parameters as a function of culture time in the Caco-2 cell model. Eur J Pharm Sci. 2004;21:77-86.
    • (2004) Eur J Pharm Sci , vol.21 , pp. 77-86
    • Bravo, S.A.1    Nielsen, C.U.2    Amstrup, J.3    Frokjaer, S.4    Brodin, B.5
  • 69
    • 13544249791 scopus 로고    scopus 로고
    • Comparison of different intestinal epithelia as models for absorption enhancement studies
    • Legen I, Salobir M, Kerc J. Comparison of different intestinal epithelia as models for absorption enhancement studies. Int J Pharm. 2005;291:183-8.
    • (2005) Int J Pharm , vol.291 , pp. 183-188
    • Legen, I.1    Salobir, M.2    Kerc, J.3
  • 70
    • 0031585529 scopus 로고    scopus 로고
    • Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy
    • Delezay O, Yahi N, Tamalet C, Baghdiguian S, Boudier JA, Fantini J. Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. Virology. 1997;238:231-42.
    • (1997) Virology , vol.238 , pp. 231-242
    • Delezay, O.1    Yahi, N.2    Tamalet, C.3    Baghdiguian, S.4    Boudier, J.A.5    Fantini, J.6
  • 71
    • 38449084547 scopus 로고    scopus 로고
    • Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
    • Hubatsch I, Ragnarsson EG, Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat Protoc. 2007;2:2111-9.
    • (2007) Nat Protoc , vol.2 , pp. 2111-2119
    • Hubatsch, I.1    Ragnarsson, E.G.2    Artursson, P.3
  • 72
    • 0033165880 scopus 로고    scopus 로고
    • Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models
    • Meaney C, O'Driscoll C. Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models. Eur J Pharm Sci. 1999;8:167-75.
    • (1999) Eur J Pharm Sci , vol.8 , pp. 167-175
    • Meaney, C.1    O'Driscoll, C.2
  • 73
    • 0344983259 scopus 로고    scopus 로고
    • In vitro trans-monolayer permeability calculations: often forgotten assumptions
    • Youdim KA, Avdeef A, Abbott NJ. In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Discovery Today. 2003;8:997-1003.
    • (2003) Drug Discovery Today , vol.8 , pp. 997-1003
    • Youdim, K.A.1    Avdeef, A.2    Abbott, N.J.3
  • 75
    • 0032727054 scopus 로고    scopus 로고
    • Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450
    • Erickson DA, Mather G, Trager WF, Levy RH, Keirns JJ. Characterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450. Drug Metab Dispos. 1999;27:1488-95.
    • (1999) Drug Metab Dispos , vol.27 , pp. 1488-1495
    • Erickson, D.A.1    Mather, G.2    Trager, W.F.3    Levy, R.H.4    Keirns, J.J.5
  • 76
    • 79956190810 scopus 로고    scopus 로고
    • Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals
    • Pal D, Kwatra D, Minocha M, Paturi DK, Budda B, Mitra AK. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sci. 2011;88:959-71.
    • (2011) Life Sci , vol.88 , pp. 959-971
    • Pal, D.1    Kwatra, D.2    Minocha, M.3    Paturi, D.K.4    Budda, B.5    Mitra, A.K.6
  • 78
    • 84918571739 scopus 로고    scopus 로고
    • Efflux pump-mediated resistance in chemotherapy
    • Ughachukwu P, Unekwe P. Efflux pump-mediated resistance in chemotherapy. Ann Med Health Sci Res. 2012;2:191-8.
    • (2012) Ann Med Health Sci Res , vol.2 , pp. 191-198
    • Ughachukwu, P.1    Unekwe, P.2
  • 80
    • 84891885073 scopus 로고    scopus 로고
    • Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics
    • Pfeifer ND, Hardwick RN, Brouwer KL. Role of hepatic efflux transporters in regulating systemic and hepatocyte exposure to xenobiotics. Ann Rev Pharmacol Toxicol. 2014;54:509-35.
    • (2014) Ann Rev Pharmacol Toxicol , vol.54 , pp. 509-535
    • Pfeifer, N.D.1    Hardwick, R.N.2    Brouwer, K.L.3
  • 81
    • 33747352798 scopus 로고    scopus 로고
    • MDR- and CYP3A4-mediated drug-drug interactions
    • Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-drug interactions. J Neuroimmune Pharmacol. 2006;1:323-39.
    • (2006) J Neuroimmune Pharmacol , vol.1 , pp. 323-339
    • Pal, D.1    Mitra, A.K.2
  • 82
    • 84964692743 scopus 로고    scopus 로고
    • Involvement of drug transporters in organ toxicity: the fundamental basis of drug discovery and development
    • Cheng Y, El-Kattan A, Zhang Y, Ray AS, Lai Y. Involvement of drug transporters in organ toxicity: the fundamental basis of drug discovery and development. Chem Res Toxicol. 2016;29:545-63.
    • (2016) Chem Res Toxicol , vol.29 , pp. 545-563
    • Cheng, Y.1    El-Kattan, A.2    Zhang, Y.3    Ray, A.S.4    Lai, Y.5
  • 83
    • 4243050943 scopus 로고    scopus 로고
    • Ivermectin: does P-glycoprotein play a role in neurotoxicity?
    • Edwards G. Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J. 2003;2 Suppl 1:S8.
    • (2003) Filaria J , vol.2 , pp. S8
    • Edwards, G.1
  • 84
    • 0035164622 scopus 로고    scopus 로고
    • Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene
    • Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001;11:727-33.
    • (2001) Pharmacogenetics , vol.11 , pp. 727-733
    • Mealey, K.L.1    Bentjen, S.A.2    Gay, J.M.3    Cantor, G.H.4
  • 87
    • 0035810631 scopus 로고    scopus 로고
    • Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment
    • Hoerauf A, Mand S, Adjei O, Fleischer B, Buttner DW. Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet. 2001;357:1415-6.
    • (2001) Lancet , vol.357 , pp. 1415-1416
    • Hoerauf, A.1    Mand, S.2    Adjei, O.3    Fleischer, B.4    Buttner, D.W.5
  • 88
    • 4544240272 scopus 로고    scopus 로고
    • The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus
    • Awadzi K, Edwards G, Opoku NO, Ardrey AE, Favager S, Addy ET, Attah SK, Yamuah LK, Quartey BT. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Ann Trop Med Parasitol. 2004;98:595-614.
    • (2004) Ann Trop Med Parasitol , vol.98 , pp. 595-614
    • Awadzi, K.1    Edwards, G.2    Opoku, N.O.3    Ardrey, A.E.4    Favager, S.5    Addy, E.T.6    Attah, S.K.7    Yamuah, L.K.8    Quartey, B.T.9
  • 89
    • 34250863207 scopus 로고    scopus 로고
    • Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor
    • Agarwal S, Pal D, Mitra AK. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor. Int J Pharm. 2007;339:139-47.
    • (2007) Int J Pharm , vol.339 , pp. 139-147
    • Agarwal, S.1    Pal, D.2    Mitra, A.K.3
  • 90
    • 57349197111 scopus 로고    scopus 로고
    • Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir
    • Janneh O, Hartkoorn RC, Jones E, Owen A, Ward SA, Davey R, Back DJ, Khoo SH. Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir. Br J Pharmacol. 2008;155:875-83.
    • (2008) Br J Pharmacol , vol.155 , pp. 875-883
    • Janneh, O.1    Hartkoorn, R.C.2    Jones, E.3    Owen, A.4    Ward, S.A.5    Davey, R.6    Back, D.J.7    Khoo, S.H.8
  • 91
    • 85018298437 scopus 로고    scopus 로고
    • SAQUINAVIR | C38H50N6O5
    • Accessed 16 Dec 2016
    • PubChem. 2016. SAQUINAVIR | C38H50N6O5 - https://pubchem.ncbi.nlm.nih.gov/compound/441243. Accessed 16 Dec 2016.
    • (2016)
  • 92
    • 85018355458 scopus 로고    scopus 로고
    • Lopinavir | C37H48N4O5
    • Accessed 16 Dec 2016
    • PubChem. 2016. Lopinavir | C37H48N4O5 - https://pubchem.ncbi.nlm.nih.gov/compound/92727. Accessed 16 Dec 2016.
    • (2016)
  • 93
    • 79953330181 scopus 로고    scopus 로고
    • Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells
    • Diker B, Janneh O, van Heeswijk RP, Copeland KF. Comparative efflux of saquinavir, ritonavir and lopinavir from primary human cells. Drug MetabLett. 2010;4:241-5.
    • (2010) Drug MetabLett , vol.4 , pp. 241-245
    • Diker, B.1    Janneh, O.2    Heeswijk, R.P.3    Copeland, K.F.4
  • 95
    • 37549018985 scopus 로고    scopus 로고
    • Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors
    • Weiss J, Weis N, Ketabi-Kiyanvash N, Storch CH, Haefeli WE. Comparison of the induction of P-glycoprotein activity by nucleotide, nucleoside, and non-nucleoside reverse transcriptase inhibitors. Eur J Pharmacol. 2008;579:104-9.
    • (2008) Eur J Pharmacol , vol.579 , pp. 104-109
    • Weiss, J.1    Weis, N.2    Ketabi-Kiyanvash, N.3    Storch, C.H.4    Haefeli, W.E.5
  • 96
    • 33847366629 scopus 로고    scopus 로고
    • Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors
    • Weiss J, Theile D, Ketabi-Kiyanvash N, Lindenmaier H, Haefeli WE. Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors. Drug Metab Dispos. 2007;35:340-4.
    • (2007) Drug Metab Dispos , vol.35 , pp. 340-344
    • Weiss, J.1    Theile, D.2    Ketabi-Kiyanvash, N.3    Lindenmaier, H.4    Haefeli, W.E.5
  • 98
    • 79251493055 scopus 로고    scopus 로고
    • An exploratory study of two Caco-2 cell models for oral absorption: a report on their within-laboratory and between-laboratory variability, and their predictive capacity
    • Prieto P, Hoffmann S, Tirelli V, Tancredi F, Gonzalez I, Bermejo M, De Angelis I. An exploratory study of two Caco-2 cell models for oral absorption: a report on their within-laboratory and between-laboratory variability, and their predictive capacity. Altern Lab Anim. 2010;38:367-86.
    • (2010) Altern Lab Anim , vol.38 , pp. 367-386
    • Prieto, P.1    Hoffmann, S.2    Tirelli, V.3    Tancredi, F.4    Gonzalez, I.5    Bermejo, M.6    Angelis, I.7
  • 99
    • 78650517988 scopus 로고    scopus 로고
    • Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?
    • Turco L, Catone T, Caloni F, Di Consiglio E, Testai E, Stammati A. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human? Toxicol in vitro. 2011;25:13-20.
    • (2011) Toxicol in vitro , vol.25 , pp. 13-20
    • Turco, L.1    Catone, T.2    Caloni, F.3    Consiglio, E.4    Testai, E.5    Stammati, A.6
  • 100
    • 67650373884 scopus 로고    scopus 로고
    • Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility
    • Messerli SM, Kasinathan RS, Morgan W, Spranger S, Greenberg RM. Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Mol Biochem Parasitol. 2009;167:54-9.
    • (2009) Mol Biochem Parasitol , vol.167 , pp. 54-59
    • Messerli, S.M.1    Kasinathan, R.S.2    Morgan, W.3    Spranger, S.4    Greenberg, R.M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.